Effect of TNFα on osteoblastogenesis from mesenchymal stem cells

Biochim Biophys Acta. 2014 Mar;1840(3):1209-13. doi: 10.1016/j.bbagen.2013.12.013. Epub 2013 Dec 19.

Abstract

Background: Bone destruction and osteoporosis are accelerated in chronic inflammatory diseases, such as rheumatoid arthritis (RA) and periodontitis, in which many studies have shown the proinflammatory cytokines, especially TNFα, play an important role; TNFα causes osteoclast-induced bone destruction as well as the inhibition of osteoblastogenesis.

Scope of review: Here we review our current understanding of the mechanism of the effect of TNFα on osteoblastogenesis from mesenchymal stem cells (MSCs). We also highlight the function of MSC in the pathogenesis of autoimmune diseases.

Major conclusions: Many studies have revealed that TNFα inhibits osteoblastogenesis through several mechanisms. On the other hand, it has been also reported that TNFα promotes osteoblastogenesis. These discrepancies may depend on the cellular types, the model animals, and the timing and duration of TNFα administration.

General significance: A full understanding of the role and function of TNFα on osteoblastogenesis from MSC may lead to targeted new therapies for chronic inflammation diseases, such as RA and periodontitis.

Keywords: Osteoblastogenesis; TNF-alpha; Wnt signaling pathway.

Publication types

  • Review

MeSH terms

  • Animals
  • Arthritis, Rheumatoid / etiology
  • Arthritis, Rheumatoid / therapy
  • Cell Differentiation / drug effects
  • Humans
  • Lupus Erythematosus, Systemic / etiology
  • Lupus Erythematosus, Systemic / therapy
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects*
  • Osteoblasts / cytology
  • Osteoblasts / drug effects*
  • Osteogenesis / drug effects*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Tumor Necrosis Factor-alpha